Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2021
[Current Status of the Pharmacological Treatment of Glaucoma and Its Prospects]Masamitsu Shimazawa, Hideaki Hara
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 7, 2018
[Establishment of retinal disease models using non-human primates and its strategy for drug discovery]Masamitsu Shimazawa, Hideaki Hara
European Journal of Pharmacology|December 3, 2014
The kallikrein system in retinal damage/protectionTomomi Masuda, Masamitsu Shimazawa, Hideaki Hara
Oxidative Medicine and Cellular Longevity|February 15, 2017
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone)Tomomi Masuda, Masamitsu Shimazawa, Hideaki Hara
CNS Neuroscience & Therapeutics|June 18, 2010
REVIEW: An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in miceYasushi Ito, Masamitsu Shimazawa, Hideaki Hara
Cellular and Molecular Neurobiology|May 1, 2019
VGF has Roles in the Pathogenesis of Major Depressive Disorder and Schizophrenia: Evidence from Transgenic Mouse ModelsTakahiro Mizoguchi, Hideaki Hara, Masamitsu Shimazawa
Biological & Pharmaceutical Bulletin|February 1, 2023
3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant HuntingtinNoria Okada, Shinsuke Nakamura, Masamitsu Shimazawa
Brain Research|June 15, 2004
Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension modelsTakazumi Taniguchi, Masamitsu Shimazawa, Hideaki Hara
Pageof 35